Ávila de Oliveira Júlia, Bazán Paulo Rodrigo, de Oliveira Claudia Eunice Neves, Treza Renata de Castro, Hondo Sandy Mikie, Los Angeles Emanuele, Bernardo Claudionor, de Oliveira Luana Dos Santos, Carvalho Margarete de Jesus, de Lima-Pardini Andrea C, Coelho Daniel Boari
Human Motor Systems Laboratory, School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil.
Instituto do Cérebro, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Eur J Neurosci. 2021 Dec;54(11):8020-8028. doi: 10.1111/ejn.15522. Epub 2021 Nov 25.
In individuals with Parkinson's disease (PD), the medication induces different and inconsistent results in the spatiotemporal parameters of gait, making it difficult to understand its effects on gait. As spatiotemporal gait parameters have been reported to be affected by gait speed, it is essential to consider the gait speed when studying walking biomechanics to interpret the results better when comparing the gait pattern of different conditions. Since the medication alters the self-selected gait speed of individuals with PD, this study analysed whether the change in gait speed can explain the selective effects of l-DOPA on the spatiotemporal parameters of gait in individuals with PD. We analysed the spatiotemporal gait parameters at the self-selected speed of 22 individuals with PD under ON and OFF states of l-DOPA medication. Bayesian mediation analysis evaluated which gait variables were affected by the medication state and checked if those effects were mediated by speed changes induced by medication. The gait speed was significantly higher among ON compared with OFF medication. All the spatiotemporal parameters of the gait were mediated by speed, with proportions of mediation close to 1 (effect entirely explained by speed changes). Our results show that a change in gait speed better explains the changes in the spatiotemporal gait parameters than the ON-OFF phenomenon. As an implication for rehabilitation, our results suggest that it is possible to assess the effect of l-DOPA on improving motor symptoms related to gait disorders by measuring gait speed.
在帕金森病(PD)患者中,药物治疗会在步态的时空参数上引发不同且不一致的结果,这使得人们难以理解其对步态的影响。由于据报道时空步态参数会受到步态速度的影响,因此在研究步行生物力学时考虑步态速度至关重要,以便在比较不同状况下的步态模式时能更好地解释结果。鉴于药物会改变PD患者的自选步态速度,本研究分析了步态速度的变化是否能够解释左旋多巴(l-DOPA)对PD患者步态时空参数的选择性影响。我们分析了22名PD患者在l-DOPA药物开启和关闭状态下自选速度时的时空步态参数。贝叶斯中介分析评估了哪些步态变量受药物状态影响,并检查这些影响是否由药物引起的速度变化介导。与药物关闭状态相比,药物开启状态下的步态速度显著更高。步态的所有时空参数均由速度介导,中介比例接近1(效应完全由速度变化解释)。我们的结果表明,与开-关现象相比,步态速度的变化能更好地解释时空步态参数的变化。作为对康复的启示,我们的结果表明通过测量步态速度有可能评估l-DOPA对改善与步态障碍相关的运动症状的效果。